Jeremy Charles Bates, | |
338 E Bannock St, Boise, ID 83712-6207 | |
(208) 336-0895 | |
Not Available |
Full Name | Jeremy Charles Bates |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 11 Years |
Location | 338 E Bannock St, Boise, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245669324 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 41433 (Idaho) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | RNA-892A (Idaho) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Regional Medical Center | Boise, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anesthesia Associates Of Boise, P.a. | 2668385287 | 153 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.
Research by ZoomDoc, a GP on-demand service, has found that patients on average have to wait for over 10 days to see a GP in Greater London if they look for an appointment on Wednesday.
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
› Verified 1 days ago
Entity Name | Anesthesia Associates Of Boise, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033147467 PECOS PAC ID: 2668385287 Enrollment ID: O20031110000655 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.
Research by ZoomDoc, a GP on-demand service, has found that patients on average have to wait for over 10 days to see a GP in Greater London if they look for an appointment on Wednesday.
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
› Verified 1 days ago
Entity Name | Intermountain Ambulatory Anesthesia, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073546289 PECOS PAC ID: 0345235180 Enrollment ID: O20040420000128 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.
Research by ZoomDoc, a GP on-demand service, has found that patients on average have to wait for over 10 days to see a GP in Greater London if they look for an appointment on Wednesday.
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jeremy Charles Bates, 1847 W Whitestone Ct, Meridian, ID 83646-1308 Ph: (208) 680-5168 | Jeremy Charles Bates, 338 E Bannock St, Boise, ID 83712-6207 Ph: (208) 336-0895 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.
Research by ZoomDoc, a GP on-demand service, has found that patients on average have to wait for over 10 days to see a GP in Greater London if they look for an appointment on Wednesday.
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
› Verified 1 days ago
Mr. Douglas Neurath, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 | |
Jordan B Wolff, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 Fax: 208-338-1796 | |
Nathan S Call, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Ashton Mieritz, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 | |
Kenneth Clark Stratton Jr., CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2559 | |
Diana San Juan Shimko, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-6416 | |
David Hansen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 338 E Bannock St, Boise, ID 83712 Phone: 208-336-0895 |